Fed Circuit Watch: Obviousness-Type Double Patenting Does Not Preclude §156 Patent Term Extension
This is the second case dealing with Novartis in which the Court of Appeals for the Federal Circuit has handed down a decision related to patent term. While the facts of this case, Novartis AG v....